RG5 Investments Inc. and Albert Sheeler agreed to acquire Gardina Pharmaceutical SAS from Wayland Group Corp. (CNSX:WAYL) for CAD 0.3 million on February 2, 2020. The consideration will be paid in installments by May 31, 2020. On February 6, 2020, Wayland Group filed a motion to approve the agreement in Ontario Superior Court of Justice. The court granted an approval on February 12, 2020. Transaction remains subject to the satisfaction of certain conditions to closing and to the receipt of the consent of the holders of not less than two-thirds of the outstanding principal amount of Wayland’s secured convertible debentures.